KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Amortization of Deferred Charges: 2020-2025

Historic Amortization of Deferred Charges for Hims & Hers Health (HIMS) over the last 1 years, with Sep 2025 value amounting to $1.7 million.

  • Hims & Hers Health's Amortization of Deferred Charges was N/A to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $144,000 for FY2021, which is 55.28% down from last year.
  • According to the latest figures from Q3 2025, Hims & Hers Health's Amortization of Deferred Charges is $1.7 million, which was up 1,110.42% from $144,000 recorded in Q1 2021.
  • Hims & Hers Health's Amortization of Deferred Charges' 5-year high stood at $1.7 million during Q3 2025, with a 5-year trough of $144,000 in Q1 2021.
  • In the last 1 years, Hims & Hers Health's Amortization of Deferred Charges had a median value of $1.7 million in 2025 and averaged $1.7 million.
  • Data for Hims & Hers Health's Amortization of Deferred Charges shows a peak YoY skyrocketed of 71.43% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Hims & Hers Health's Amortization of Deferred Charges stood at $144,000 in 2021, then followed by $1.7 million in 2025.
  • Its Amortization of Deferred Charges was $1.7 million in Q3 2025, compared to $144,000 in Q1 2021 and $71,000 in Q4 2020.